Monalizumab in Patients With Recurrent/Metastatic SCCHN
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
Eur. J. Cancer 2021 Nov 01;158(xx)17-26, R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, P Debruyne, S Henry, S Zanetta, A Rutten, L Licitra, JL Canon, MC Kaminsky, P Specenier, S Rottey, J Guigay, A Kong, I Tinhofer, E Borcoman, L Dirix, T Raveloarivahy, C Fortpied, M Vanlancker, M Morfouace, AS Govaerts, JP MachielsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.